Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions

Summary

Phase 1 study to evaluate the safety and the pharmacokinetics of "UI111" and "UIC202006" in healthy adult volunteers under fed state conditions \- Open-label, randomized, single-dose, 2-sequence, 4-period, crossover design

Timeline

Start

2025-02-13

Primary completion

2025-03-10

Completion

2025-03-26

Drugs

Indications